» Articles » PMID: 33479401

Catechin and Curcumin Interact with S Protein of SARS-CoV2 and ACE2 of Human Cell Membrane: Insights from Computational Studies

Overview
Journal Sci Rep
Specialty Science
Date 2021 Jan 22
PMID 33479401
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

The recent outbreak of the coronavirus (SARS-CoV2) is an unprecedented threat to human health and society across the globe. In this context, development of suitable interventions is the need of the hour. The viral spike protein (S Protein) and the cognate host cell receptor ACE2 can be considered as effective and appropriate targets for interventions. It is evident from the present computational study, that catechin and curcumin, not only exhibit strong binding affinity to viral S Protein and host receptor ACE2 but also to their complex (receptor-binding domain (RBD) of the spike protein of SARS-CoV2 and ACE2; RBD/ACE2-complex). The binding affinity values of catechin and curcumin for the S protein, ACE2 and RBD/ACE2-complex are - 10.5 and - 7.9 kcal/mol; - 8.9 and - 7.8 kcal/mol; and - 9.1 and - 7.6 kcal/mol, respectively. Curcumin directly binds to the receptor binding domain (RBD) of viral S Protein. Molecular simulation study over a period of 100 ns further substantiates that such interaction within RBD site of S Protein occurs during 40-100 ns out of 100 ns simulation trajectory. Contrary to this, catechin binds with amino acid residues present near the RBD site of S Protein and causes fluctuation in the amino acid residues of the RBD and its near proximity. Both catechin and curcumin bind the interface of 'RBD/ACE2-complex' and intervene in causing fluctuation of the alpha helices and beta-strands of the protein complex. Protein-protein interaction studies in presence of curcumin or catechin also corroborate the above findings suggesting the efficacy of these two polyphenols in hindering the formation of S Protein-ACE2 complex. In conclusion, this computational study for the first time predicts the possibility of above two polyphenols for therapeutic strategy against SARS-CoV2.

Citing Articles

Dimethoxycurcumin Acidifies Endolysosomes and Inhibits SARS-CoV-2 Entry.

Khan N, Afghah Z, Baral A, Geiger J, Chen X Front Virol. 2024; 2.

PMID: 39677976 PMC: 11638979. DOI: 10.3389/fviro.2022.923018.


Angiotensin-Converting Enzyme-2 (ACE2) Downregulation During Coronavirus Infection.

Nor Rashid N, Amrani L, Alwan A, Mohamed Z, Yusof R, Rothan H Mol Biotechnol. 2024; .

PMID: 39266903 DOI: 10.1007/s12033-024-01277-5.


In vitro study on efficacy of SKF7, a Malaysian medicinal plant product against SARS-CoV-2.

Abd Razak M, Md Jelas N, Norahmad N, Mohmad Misnan N, Muhammad A, Padlan N BMC Complement Med Ther. 2024; 24(1):333.

PMID: 39261916 PMC: 11389526. DOI: 10.1186/s12906-024-04628-6.


Possible roles of phytochemicals with bioactive properties in the prevention of and recovery from COVID-19.

Koyama S, Joseph P, Shields V, Heinbockel T, Adhikari P, Kaur R Front Nutr. 2024; 11:1408248.

PMID: 39050135 PMC: 11266003. DOI: 10.3389/fnut.2024.1408248.


Effect of polyphenols against complications of COVID-19: current evidence and potential efficacy.

Vajdi M, Karimi A, Hassanizadeh S, Farhangi M, Bagherniya M, Askari G Pharmacol Rep. 2024; 76(2):307-327.

PMID: 38498260 DOI: 10.1007/s43440-024-00585-6.


References
1.
Song J, Lee K, Seong B . Antiviral effect of catechins in green tea on influenza virus. Antiviral Res. 2005; 68(2):66-74. DOI: 10.1016/j.antiviral.2005.06.010. View

2.
Kalita P, Padhi A, Zhang K, Tripathi T . Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2. Microb Pathog. 2020; 145:104236. PMC: 7196559. DOI: 10.1016/j.micpath.2020.104236. View

3.
Mustafa S, Balkhy H, Gabere M . Peptide-Protein Interaction Studies of Antimicrobial Peptides Targeting Middle East Respiratory Syndrome Coronavirus Spike Protein: An In Silico Approach. Adv Bioinformatics. 2019; 2019:6815105. PMC: 6634063. DOI: 10.1155/2019/6815105. View

4.
Dairaku I, Han Y, Yanaka N, Kato N . Inhibitory effect of curcumin on IMP dehydrogenase, the target for anticancer and antiviral chemotherapy agents. Biosci Biotechnol Biochem. 2010; 74(1):185-7. DOI: 10.1271/bbb.90568. View

5.
Ge X, Li J, Yang X, Chmura A, Zhu G, Epstein J . Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature. 2013; 503(7477):535-8. PMC: 5389864. DOI: 10.1038/nature12711. View